Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (Nasdaq: OCEA) is a clinical-stage biopharmaceutical company that completed its de-SPAC business combination with Aesther Healthcare Acquisition Corp. in February 2023, with Aesther Healthcare Holdings LLC serving as the SPAC's sponsor. Aesther Healthcare Acquisition Corp. conducted its IPO in 2021 targeting the healthcare and life sciences sector. Ocean Biomedical is developing novel therapies across oncology, pulmonary fibrosis, and infectious disease, with its pipeline rooted in technology licensed from Brown University. The company filed an S-1/A amendment with the SEC on June 15, 2023, as part of its ongoing post-merger registration obligations. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics on OCEA and hundreds of other SPAC transactions.